GlucoTrack, Inc. GCTK

Full chart Compare
Set alert

Price alert · GCTK

All alert types
0.41 USD -0.03 (-6.82%)

Nov 4, 2026, 11:24 AM EST

0.41 Day range 0.7604
0.342 52-week range 207.00
YTD
-99.65%
1 year
-99.79%
Market cap
580.22K
EPS (ttm)
-246.30
Shares out
14.49M
YTD return
-99.65%
1-year return
-99.79%
Volume
4.68K
Avg volume
1.88M
Open
0.4402
Previous close
0.44
Day's range
0.41 – 0.7604
52-week range
0.342 – 207.00
Beta
0.16

5Y -719,999.5600 (-100.00%)

0.0000250,000.0000500,000.0000750,000.0000202220232024202520260.4400

Key statistics

Enterprise value
1.60M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.35
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-4.69M
Total cash
159.00K
Total debt
274.00K
Return on equity
-541.13%
Short % of float
0.83%
50-day average
0.97332
200-day average
1.89

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
GCTK Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GCTK Net income — quarterly -3.81M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GCTK EPS — quarterly -22.80
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on GCTK — it syncs with the Stock Master app.

Insider holders

GCTK insider holders
InsiderRelationLatest transactionDateShares held
SYCOFF ANDREWDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseApr 21, 20242,951,260

Institution ownership

GCTK institution ownership
Holder% heldSharesValueReported
Geode Capital Management, LLC0.47%27,1617.17KSep 29, 2024
Alerus Financial NA0.24%13,8553.66KSep 29, 2024
Cetera Investment Advisers0.17%10,0002.64KSep 29, 2024
UBS Group AG0.05%3,085814Sep 29, 2024
Tower Research Capital LLC (TRC)0.01%432114Sep 29, 2024
Morgan Stanley0.01%500131Sep 29, 2024

Fund ownership

GCTK fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.37%21,6135.71KOct 30, 2024
Fidelity Series Total Market Index Fund0.09%5,0641.34KOct 30, 2024